Clinically Significant Interactions with Benzodiazepines

作者: Jose Valdes , Douglas L. Boggs , Angela A. Boggs , Jose A. Rey

DOI: 10.1007/978-3-319-27883-4_19

关键词:

摘要: Benzodiazepines are a class of lipophilic compounds used for variety indications including anxiety disorders, insomnia, epilepsy, musculoskeletal and as sedatives during surgery. The chemical nucleus each benzodiazepine well their pharmacodynamic activity is identical. However, alterations to this basic structure lead numerous benzodiazepines with different pharmacokinetic properties lipid solubility resulting in agents differing rates elimination, concentrations, volumes distribution, potencies. In chapter we will review the varied kinetics available discuss metabolic pathways leading excretion these medications. This includes enzymes (Phase I Phase II) responsible metabolism parent compound intermediates. We also pharmacologic intermediate metabolites. Furthermore identify interactions including: drug-drug interactions, P-gylcoprotein protein-binding food/herbal interactions. Other factors that may require dosing such weight, sex, age, smoking status, genetic polymorphisms, similarly be discussed. Finally clinical monitoring required individuals being prescribed respiratory depression, sedation, withdrawal. goal give reader background should considered when choosing or practice.

参考文章(95)
Maria E Camacho, Charles M Morin, None, The effect of temazepam on respiration in elderly insomniacs with mild sleep apnea Sleep. ,vol. 18, pp. 644- 645 ,(1995) , 10.1093/SLEEP/18.8.644
David J. Greenblatt, C. Eugene Wright, Clinical pharmacokinetics of alprazolam. Therapeutic implications Clinical Pharmacokinectics. ,vol. 24, pp. 453- 471 ,(1993) , 10.2165/00003088-199324060-00003
William E. Smoyer, Jeffrey S. Berns, George R. Aronoff, Nishaminy Kasbekar, Deborah A. Pasko, Bruce A. Mueller, Michael E. Brier, William M. Bennett, Drug prescribing in renal failure : dosing guidelines for adults and children American College of Physicians. ,(2007)
Vozeh S, Pharmacokinetic of benzodiazepines in old age Schweizerische Medizinische Wochenschrift. ,vol. 111, pp. 1789- ,(1981)
J S Harmatz, R I Shader, D J Greenblatt, K Franke, Pharmacokinetics of chlordiazepoxide and metabolites following single and multiple oral doses International journal of clinical pharmacology and biopharmacy. ,vol. 16, pp. 486- 493 ,(1978)
Catherine Lucas, Jennifer Martin, Smoking and drug interactions Australian Prescriber. ,vol. 36, pp. 102- 104 ,(2013) , 10.18773/AUSTPRESCR.2013.037
A Dahan, H Altman, Food-drug interaction: grapefruit juice augments drug bioavailability--mechanism, extent and relevance. European Journal of Clinical Nutrition. ,vol. 58, pp. 1- 9 ,(2004) , 10.1038/SJ.EJCN.1601736
Vibeke Andersen, Natalie Pedersen, Niels-Erik Larsen, Jesper Sonne, Steen Larsen, Intestinal first pass metabolism of midazolam in liver cirrhosis – effect of grapefruit juice British Journal of Clinical Pharmacology. ,vol. 54, pp. 120- 124 ,(2002) , 10.1046/J.1365-2125.2002.01615.X
X QIN, H XIE, W WANG, N HE, S HUANG, Z XU, D OUYANG, Y WANG, H ZHOU, Effect of the gene dosage of CYP2C19 on diazepam metabolism in Chinese subjects Clinical Pharmacology & Therapeutics. ,vol. 66, pp. 642- 646 ,(1999) , 10.1053/CP.1999.V66.103379001
David J. Greenblatt, Jerold S. Harmatz, Nikhilesh N. Singh, Frank Steinberg, Thomas Roth, Margaret L. Moline, Stephen C. Harris, Ram P. Kapil, Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration. The Journal of Clinical Pharmacology. ,vol. 54, pp. 282- 290 ,(2014) , 10.1002/JCPH.220